If you are searching for some new additions to boost your income portfolio, then the two ASX dividend shares in this article could be worth a look.
That's the view of analysts at Bell Potter, who believe they are among the best to buy now. Here's what they are recommending:
Image source: Getty Images
Dalrymple Bay Infrastructure Ltd (ASX: DBI)
This infrastructure stock could be an ASX dividend share to buy according to Bell Potter.
In fact, it recently sold down its holding in fellow infrastructure stock APA Group (ASX: APA) to fund its position. The broker believes it has a superior long term outlook thanks to its simpler business and predictable growth profile. It explains:
Brookfield completed its exit from DBI, selling its final 26% stake via a block trade. The sell-down created short-term pressure on the share price, and we used this weakness as an opportunity to reposition our real asset/infrastructure exposure. We funded our new position in DBI by exiting APA. We believe DBI presents a superior long-term opportunity due to its simpler, single-asset structure and more predictable growth profile.
In respect to dividends, Bell Potter expects partially franked dividend yields of 5.6% to 6% over the next three years.
Sonic Healthcare Ltd (ASX: SHL)
Another ASX dividend share that Bell Potter is recommending to clients is healthcare company Sonic Healthcare.
It highlights that Sonic is attractive from a dividend perspective due to its growing earnings and rising yields. This is being underpinned by a stabilising operating environment and structural trends. Bell Potter commented:
Sonic Healthcare is a stock that looks attractive on a dividend screen, with rising yields and sustained earnings growth supporting the security of income for investors. SHL's performance has been inconsistent over previous periods where COVID-19 artificially inflated margins, as the business pivoted to provide testing services, with the subsequent decline post-COVID negatively impacting earnings.
We expect the operating environment for SHL to stabilise, with structural population trends providing a tailwind for the business and management's efficiency initiatives beginning to drive margin improvement. Looking ahead, the forecast return to earnings growth in FY26–28 appears relatively defensive, underpinned by SHL's geographically diverse revenue base and the non-cyclical nature of healthcare spending.
As for income, Bell Potter is forecasting partially franked dividend yields of approximately 5% each year for the next three years.
